Parallax Volatility Advisers, L.P. Vista Gen Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.09 - $0.16 $28,314 - $50,336	-314,600 Reduced 99.46%	1,700 $0
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.07 $44,282 - $338,441	316,300 New	316,300 $48,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.